But there was more to this year than disease and strife. Big deals were done, innovations launched, and progress towards sustainability was made.
To read the roundup of the most important stories of the year, published in PKN's Nov-Dec 2020 issue, click here.
Advanced biomanufacturer, Cauldron Ferm, has raised $13.25 million in a Series A2 priced round led by Main Sequence Ventures, with participation from Horizons Ventures, SOSV, and NGS Super.
Global consumer goods business, Unilever, has confirmed it is in discussions with McCormick & Co on the sale of its Food business. Both companies have released statements saying while negotiations are ongoing there is no certainty of a deal.
Australian organisations could gain access to the world’s largest pooled research fund by early 2027, as the federal government begins treaty negotiations on association to Horizon Europe, the European Union’s $155 billion flagship research and innovation funding program.
